Kimberly Maersk-Moller - 24 Jun 2024 Form 3 Insider Report for MIMEDX GROUP, INC. (MDXG)

Role
Chief Commercial Officer
Signature
/s/ William F. Hulse, as attorney-in-fact for Kimberly Maersk-Moller
Issuer symbol
MDXG
Transactions as of
24 Jun 2024
Net transactions value
$0
Form type
3
Filing time
03 Jul 2024, 21:29:17 UTC
Next filing
13 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MDXG Common Stock 62,383 24 Jun 2024 Direct F1
holding MDXG Common Stock 18,366 24 Jun 2024 Direct F2
holding MDXG Common Stock 28,564 24 Jun 2024 Direct F3
holding MDXG Common Stock 32,488 24 Jun 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MDXG Stock Options 24 Jun 2024 Common Stock 39,308 $8.63 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This filing is made on behalf of a new executive officer to report their existing holdings of MiMedx Securities.
F2 Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years from the original grant date of March 2, 2022, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.
F3 Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years from the original grant date of March 13, 2023, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.
F4 Reflects grant of restricted stock units which vests fully on the third anniversary of the grant from the original grant date of March 1, 2024, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.
F5 The options granted to the reporting person shall vest 25% on each anniversary of the grant date of March 1, 2024, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.